ARTICLE | Clinical News
Mersana preclinical data
April 27, 2009 7:00 AM UTC
Mouse xenograft models of human renal cell carcinoma (RCC) showed that XMT-1107 had increased anti-angiogenic and anti-tumor activity compared with its in vivo release product XMT-1191, TNP-470 and S...